Droxinavir

Droxinavir (also known as SC 55389A) was an experimental protease inhibitor researched by Pharmacia as a treatment for HIV infection. Its research and development was discontinued on March 06, 1995.
Wikipedia contributors, "Droxinavir", Wikipedia, revision 1330274437, retrieved 20 November 2026, source, CC BY-SA 4.0.